Evidence map›Paper›PMID 25761673›Full record

ArticleNature communications2015

IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology.

Tegest Aychek, Alexander Mildner, Simon Yona, Ki-Wook Kim, Nardy Lampl, Shlomit Reich-Zeliger, Louis Boon, Nir Yogev, Ari Waisman, Daniel J Cua and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. IL-23 to see: Gut DCs shine bright in inductive sites.The Journal of experimental medicine · 2024
    Article
  11. Tackling Tissue Macrophage Heterogeneity by SplitCre Transgenesis.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Article
  13. Article
  14. Macrophages in intestinal homeostasis and inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  15. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  16. Article
  17. Review
  18. ILCs-Crucial Players in Enteric Infectious Diseases.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Tegest AychekDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Alexander MildnerDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Simon YonaDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Ki-Wook KimDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Nardy LamplDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Shlomit Reich-ZeligerDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Louis BoonBioceros, Yalelaan 46, 3584 CM Utrecht, The Netherlands.
Nir YogevInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Ari WaismanInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.ORCID 0000000343048234
Daniel J CuaMerck Research Laboratories, 901 South California Avenue, Palo Alto, California 94304-1104, USA.
Steffen JungDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Weizmann Institute of Science · ILJohannes Gutenberg University Mainz · DEMerck & Co., Inc., Rahway, NJ, USA (United States) · USPolpharma Biologics (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut homeostasis and mucosal immune defense rely on the differential contributions of dendritic cells (DC) and macrophages. Here we show that colonic CX3CR1(+) mononuclear phagocytes are critical inducers of the innate response to Citrobacter rodentium infection. Specifically, the absence of IL-23 expression in macrophages or CD11b(+) DC results in the impairment of IL-22 production and in acute lethality. Highlighting immunopathology as a death cause, infected animals are rescued by the neutralization of IL-12 or IFNγ. Moreover, mice are also protected when the CD103(+) CD11b(-) DC compartment is rendered deficient for IL-12 production. We show that IL-12 production by colonic CD103(+) CD11b(-) DC is repressed by IL-23. Collectively, in addition to its role in inducing IL-22 production, macrophage-derived or CD103(-) CD11b(+) DC-derived IL-23 is required to negatively control the otherwise deleterious production of IL-12 by CD103(+) CD11b(-) DC. Impairment of this critical mononuclear phagocyte crosstalk results in the generation of IFNγ-producing former TH17 cells and fatal immunopathology.

Indexed as

AnimalsAntigens, CDCD11b AntigenCitrobacter rodentiumColonCX3C Chemokine Receptor 1Dendritic CellsEnterobacteriaceae InfectionsGene Expression RegulationHomeostasisImmunity, InnateImmunity, MucosalIntegrin alpha ChainsInterferon-gammaInterleukin-12Interleukin-22alpha E integrinsAntigens, CDCD11b AntigenCX3C Chemokine Receptor 1CX3CR1 protein, humanIntegrin alpha ChainsInterferon-gammaInterleukin-12Interleukin-22Interleukin-23InterleukinsReceptors, Chemokine

Identifiers

PMID25761673
PMCPMC4382688
OpenAlexW2161640738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.